Prolaio
Healthcare & Life Sci
Company overview
Prolaio builds cardiovascular clinical research infrastructure that uses medical-grade wearables to collect data continuously and modernize how drug trials are run. eVO2peak is its FDA-cleared metric that estimates peak VO2 from ECG and vital-sign data. Prolaio is headquartered in Chicago, Illinois.
The company was founded in 2022 by Tassos Gianakakos and Jay Edelberg. Kardigan acquired Prolaio in February 2025. Prolaio is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Chicago, United States